Claims (14)
항생물질로 유용한 일반식(I)의 화합물 및 그것의 제약학적으로 허용가능한 산부가 또는 염기염.Compounds of formula (I) and pharmaceutically acceptable acid addition or base salts thereof useful as antibiotics.
상기 일반식(I)에서 R1은 탄소수 1~4의 저급알킬, 2-플루오로에틸, 시클로프로필, 4-플루오로페닐 또는 2,4-디플루오로페닐이고, R2는 1,2,3,4-테트라히드로-2-이소퀴놀린일, 1,2,3,4-테트라히드로-7-아미노-2-이소퀴놀린일, 1,2,3,4-테트라히드로-7-메틸아미노-2-이소퀴놀린일,5,6,7,8-테트라히드로-1,6-일, 5,6,7,8-테트라히드로-1,7-나프티리딘-7-일, 1,2,3,4-테트라히드로-2-6-나프티리딘-2-일, 1,2,3,4-테트라히드로-2,7-나프티리딘-2-일 또는 2-이소인돌린일이며, X1은 수소, 플루오로 클로로 또는 메톡시이고, X2는 수소 또는 아미노이다.In general formula (I), R 1 is lower alkyl, 2-fluoroethyl, cyclopropyl, 4-fluorophenyl or 2,4-difluorophenyl having 1 to 4 carbon atoms, and R 2 is 1,2, 3,4-tetrahydro-2-isoquinolinyl, 1,2,3,4-tetrahydro-7-amino-2-isoquinolinyl, 1,2,3,4-tetrahydro-7-methylamino- 2-isoquinolinyl, 5,6,7,8-tetrahydro-1,6-yl, 5,6,7,8-tetrahydro-1,7-naphthyridin-7-yl, 1,2,3 , 4-tetrahydro-2-6-naphthyridin-2-yl, 1,2,3,4-tetrahydro-2,7-naphthyridin-2-yl or 2-isoindolinyl, X 1 is Hydrogen, fluoro chloro or methoxy and X 2 is hydrogen or amino.
제1항에서 1-에틸-7-(1,2,3,4-테트라히드로-2-이소퀴놀린일)-6-플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-ethyl-7- (1,2,3,4-tetrahydro-2-isoquinolinyl) -6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxyl according to claim 1 mountain.
제1항에서 1-시클로프로필-7-(1,2,3,4-테트라히드로-2-이소퀴놀린일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-7- (1,2,3,4-tetrahydro-2-isoquinolinyl) -6,8-difluoro-1,4-dihydro-4-oxo-3 in claim 1 Quinolinecarboxylic acid.
제1항에서 1-시클로프로필-7-(1,2,3,4-테트라히드로-7-아미노-2-이소퀴놀린일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-7- (1,2,3,4-tetrahydro-7-amino-2-isoquinolinyl) -6,8-difluoro-1,4-dihydro-4 in claim 1 Oxo-3-quinolinecarboxylic acid.
제1항에서 1-시클로프로필-5-아미노-7-(1,2,3,4-테트라히드로-7-아미노-2-이소퀴놀린일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-5-amino-7- (1,2,3,4-tetrahydro-7-amino-2-isoquinolinyl) -6,8-difluoro-1,4- in claim 1 Dihydro-4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-(2,4-디플루오로페닐)-7-(5,6,7,8-테트라히드로-1,6-나프티리딘-6-일)-6-플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1- (2,4-difluorophenyl) -7- (5,6,7,8-tetrahydro-1,6-naphthyridin-6-yl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-(2-플루오로에틸)-7-(5,6,7,8-테트라히드로-1,6-나프티리딘-6-일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1- (2-fluoroethyl) -7- (5,6,7,8-tetrahydro-1,6-naphthyridin-6-yl) -6,8-difluoro-1 in claim 1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-(3급부틸)-7-(5,6,7,8-테트라히드로-1,6-나프티리딘-6-일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1- (tertbutyl) -7- (5,6,7,8-tetrahydro-1,6-naphthyridin-6-yl) -6,8-difluoro-1,4- in claim 1 Dihydro-4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-시클로포로필-7-(5,6,7,8-테트라히드로-1,6-나프티리딘-6-일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cycloporophyl-7- (5,6,7,8-tetrahydro-1,6-naphthyridin-6-yl) -6,8-difluoro-1,4-dihydro in claim 1 4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-시클로프로필-5-아미노-7-(5,6,7,8-테트라히드로-1,6-나프티리딘-6-일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-5-amino-7- (5,6,7,8-tetrahydro-1,6-naphthyridin-6-yl) -6,8-difluoro-1,4 in claim 1 -Dihydro-4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-시클로프로필-7-(5,6,7,8-테트라히드로-1,7-나프티리딘-7-일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-7- (5,6,7,8-tetrahydro-1,7-naphthyridin-7-yl) -6,8-difluoro-1,4-dihydro- in claim 1 4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-시클로프로필-7-(1,2,3,4-테트라히드로-2,6-나프티리딘-2-일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-7- (1,2,3,4-tetrahydro-2,6-naphthyridin-2-yl) -6,8-difluoro-1,4-dihydro- in claim 1. 4-oxo-3-quinolinecarboxylic acid.
제1항에서 1-시클로프로필-7-(2-이소인돌린일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산.1-cyclopropyl-7- (2-isoindolinyl) -6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid according to claim 1.
제1항에서 1-시클로프로필-5-아미노-7-(2-이소인돌린일)-6,8-디플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산이다.Is 1-cyclopropyl-5-amino-7- (2-isoindolinyl) -6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid .
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.